34 SOL GROUP  –  CUSTOMERS, PATIENTS AND SUPPLIERS
V I V I S O L CO N T I N U E S TO P RO M OT E 
I N N OVAT I O N W I T H R E S M O N P RO D I A RY
Vivisol supported Restech S.r.l., a Milan Polytechnic  exacerbation of the disease. The doctor is therefore 
spin off, in the development and production of  able to take prompt action, adjusting the treatment 
Resmon PRO Diary, an innovative system for the  and thus preventing the patient’s condition from 
remote  management  of  patients  afflicted  with  worsening.
chronic obstructive pulmonary disease (COPD). 
The device and its algorithm were tested between 
Resmon PRO Diary is the first medical device that  2013 and 2016 in a multicentre clinical trial that 
is able to anticipate the exacerbation of COPD  demonstrated the efficacy of the monitoring action 
through domestic monitoring thanks to an inno- with an significant reduction in the rate of hospital-
vative automatic algorithm that analyses respira- isation of patients and a consequent reduction in 
tory parameters. costs for the health system. 
Resmon PRO Diary makes it possible to improve the  Resmon PRO Diary was presented during the most 
quality of life of patients in a simple and immediate  important European pulmonology congress, organ-
way: all they need to do is breathe into the device  ised by the European Respiratory Society and held 
for a minute a day and this, through the Vivisol tele- in Milan on 9 - 13 September 2017.
medicine platform, automatically sends the data to 
the patient’s doctor, communicating the possible 